Fresenius Medical Care AG & Co. KGaA FME

XET: FME | ISIN: DE0005785802   12/02/2025
46,78 EUR (+0,13%)
(+0,13%)   12/02/2025

20 december 2024 · Europees aandelennieuws · Bolero.be

Amprion en Hitachi Energy tekenen contract oor Duitse converterstations De Zwitserse leverancier van energietechnologie en elektrificatie, meldde dat het contracten ter waarde van meer dan 2 miljard dollar heeft getekend...

4 september 2024 · Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software · Persbericht

30 juli 2024 · Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 · Persbericht

12 juni 2024 · Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations · Persbericht

23 mei 2024 · Moody's and S&P change Fresenius Medical Care's rating outlook to stable · Persbericht

21 mei 2024 · Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024 · Persbericht

16 mei 2024 · Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets · Persbericht

7 mei 2024 · Fresenius Medical Care starts the year with strong earnings growth · Persbericht

22 maart 2024 · Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care · Persbericht

19 maart 2024 · Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device · Persbericht

13 maart 2024 · Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources · Persbericht

5 maart 2024 · Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador · Persbericht

20 februari 2024 · Fresenius Medical Care delivers on commitments in a year of fundamental transformation · Persbericht

8 februari 2024 · Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies · Persbericht

5 februari 2024 · Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board · Persbericht

8 januari 2024 · Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions · Persbericht

1 november 2023 · Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter · Persbericht

31 oktober 2023 · Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery · Persbericht

31 oktober 2023 · Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023 · Persbericht

26 oktober 2023 · Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset · Persbericht

Mijn selecties